CancerPartnersUK receives debt financing from RBS
Apposite welcomes new research from Cambridge Associates on sector funds
CancerPartnersUK centre in Elstree is the first to provide genetic testing in the private sector
Ultherapy® Décolletage treatment now FDA-Cleared
Ulthera to be acquired by Merz for $600 million
Ulthera, Inc. plans to enter cellulite market with acquisition of Cabochon Aesthetics, Inc.
Ulthera® system receives third FDA clearance